This week, we highlight two recent publications in MedZine. One of them is a publication in Cell by researchers of the John Hopkins Institue for Cell Engineering. The cell biologists from Baltimore performed pioneering research into the mechanisms behing the onset of Parkinson’s disease (PD) by a mutation in LRRK2. The other article, by scientists of the McGill University of Montreal published in Immunity, deals with the role of prostaglandin E2 (PGE2) in influenza A infection. The researchers showed that inhibition of PGE2 causes an increase in the survival rate of mice, when infected with a lethal dose of the influenza virus. Continue reading
Showing articles tagged with 'Parkinson'
- Platelet transfusion after stroke not beneficial for patients using antiplatelet drugs
- Mindfulness can help prevent depression relapse
- Swift blood transfusion after trauma lowers risk of death
- ‘Milestone’ in cocaine dependence treatment: dexamfetamine effective and safe
- Stress response after childhood trauma measurable in DNA
- Antibiotic resistance growing global problem for children with urinary tract infection
- Venous thromboembolism after radical cystectomy associated with lower survival of bladder cancer
- Microbirthing: a good or a bad idea?
- Researchers predict IVF failure using gene expression profiling
- Recovery sleep could compensate elevated risk of diabetes
- Preseasonal treatment with omalizumab prevents fall asthma exacerbations
- Obese patients: more mental health conditions than expected
Most popular tags
Join our newsletter
And stay updated throughout.